Bio Essence Corp (BIOE) Form 8-K — Oct 23, 2026
Bio Essence Corp. announced that shareholders holding 63.92% of outstanding common stock elected Xiying (Thea) Zhang and Geoff Fellows to the Board of Directors by written consent effective October 19, 2026. Ms. Zhang brings 15+ years in business operations and product commercialization from Spyglass Pharma and Oasis Medical, while Mr.
Key figures
- New director limit
- 10
- Prior director limit
- 3
- Shareholder consent percentage
- 63.92%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.